Online Program Home
My Program

Abstract Details

Activity Number: 558 - The Big Data Revolution in Health Care: Promise and Potential
Type: Topic Contributed
Date/Time: Wednesday, July 31, 2019 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #304425
Title: Perspectives on Use of Real-World Evidence in Drug Development
Author(s): Demissie Alemayehu* and Satrajit Roychoudhury
Companies: Pfizer, Inc. and Pfizer Inc
Keywords: Real World Evidence ; Observational Study; Confounding; Drug Development; Historical Control
Abstract:

With the growing need to enhance the efficiency of the current drug development process, regulators and pharmaceutical companies have increasingly turned their attentions to non-traditional and novel approaches and data sources. Thanks in part to the unfolding advances in predictive analytics and computing platforms, there is a renewed interest in the use of real-world evidence to complement data from randomized controlled trials. However, effective use of such data requires addressing important operational, conceptual and regulatory challenges. We elucidate pertinent aspects of the use of real world evidence in regulatory settings, with emphasis on study design, analytical strategies, data quality and regulatory requirements.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2019 program